In separate small clinical trials, two treatments showed promise that they could help patients with one of the most dire diagnoses in oncology.
Category: Drugs (Pharmaceuticals)
-
Two Drugs Stir Hope for Treatment of Deadly Pancreatic Cancer
The New York Times – Business: -
UnitedHealth Group Reports Flat First-Quarter Earnings
The New York Times – Business:One of the nation’s largest insurers, the company’s profits were higher than analysts’ expectations but still fell short of showing a significant comeback.
-
Help for Medicare Advantage Patients Who Lose Doctors Is Shelved, for Now
The New York Times – Business:Nationwide, hospital and providers are leaving private Medicare Advantage plans, putting thousands of seniors at risk of higher costs and the loss of trusted doctors.
-
Trump Revamps Metal and Pharmaceutical Tariffs
The New York Times – Business:The administration announced new levies and made changes to existing tariffs for industries that have proved influential on the president’s trade policy.
-
How A.I. Helped One Man (and His Brother) Build a $1.8 Billion Company
The New York Times – Business:Who needs more than two employees when artificial intelligence can do so many corporate tasks? It’s super efficient — and a little bit lonely.
-
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
The New York Times – Business:Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
-
FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.’s Wishes
The New York Times – Business:The peptides, which are increasingly marketed as providing longevity and health benefits, were removed in 2023 from the agency’s list of products that compounding pharmacies can sell.
-
How to Turn a Chicken Egg Into a Drug Factory
The New York Times – Business:A biotech start-up is testing a novel way of efficiently producing pharmaceutical drugs.
-
Ozempic Is About to Go Generic in India, China and Canada
The New York Times – Business:In India, China and several other nations, Novo Nordisk is on the verge of losing patent protection for its blockbuster weight loss drug, opening the door for cheaper competing versions.
-
States Move to Limit Access to H.I.V. Treatment
The New York Times – Business:Citing shortfalls in federal support, about 20 states are toughening eligibility requirements for patients in drug assistance programs.
-
Why Estrogen Patches For Menopause Are So Hard to Find
The New York Times – Business:Changing attitudes around menopause treatment have driven up demand for hormone therapy.
-
F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
The New York Times – Business:Moderna said it had held further discussions with regulators and announced that the agency would accept the company’s application for approval of its flu vaccine that uses mRNA technology.